Ado-trastuzumab Emtansine Evaluated With Docetaxel, Pertuzumab

Ado-trastuzumab Emtansine Evaluated With Docetaxel, Pertuzumab

Ado-trastuzumab emtansine in combination with docetaxel with or without pertuzumab appeared efficacious in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic locally advanced or metastatic breast cancer, a study published …

(Visited 3 times, 1 visits today)
6
Like
Save

Comments

Write a comment

*